Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at JMP Securities Life Sciences Conference Transcript

May 16, 2023 / 05:00PM GMT
Release Date Price: $4.54 (-3.20%)
Silvan Türkcan
JMP Securities LLC - Analyst

Thank you. Thanks for joining us. Welcome back to day two of the JMP Healthcare Conference. My name is Silvan Türkcan, I'm a senior analyst with JMP covering precision medicines. It's my pleasure to host Matt Norkunas, CFO of Generation Bio. Thanks so much for joining us today.

Matt Norkunas
Generation Bio Co. - CFO

Thanks, Silvan. It's nice to be here.

Silvan Türkcan
JMP Securities LLC - Analyst

Okay. So over the past 12 months, you've been very focused on the development of your technology, and as an introduction to the people that may not -- not as familiar with your story, could you please talk about your technology and how that fits into the gene therapy space?

Matt Norkunas
Generation Bio Co. - CFO

Sure, sure. When we think about our fit into the gene therapy space, I think there's really two angles to consider. One is the scientific angle, which I think the majority of the world is focused on. But I also think it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot